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Summary 
BALB/c mice infected with the intracellular protozoan Leishmania major mount a T hdper cell 
2 (Th2) response that fails to control growth of the parasite and results in the development of 
visceral leishmaniasis. Separation of CD4 + T cells into CD45RB hgh and CD45KB l~  subsets 
showed that the L. major-specific Th2 cells were contained within the CD45RB I~  population 
as these cells produced high levels of antigen-specific interleukin 4 (IL-4) in vitro and transferred 
a nonhealing response to L. major-infected C.B-17 scid mice. In contrast, the CD45RBh'ghCD4 + 
population contained L. major-reactive cells that produced interferon 3, (IFN-'y) in vitro and 
transferred a healing Thl response to L. major-infected  C.B-17 scid mice. Transfer of the Thl 
response by the CD45R.B  hSh population was inhibited by the CD45RB l~  population by a 
mechanism  that was dependent on IL-4. These data indicate that L.  major-specific Thl cells 
do develop in BALB/c mice, but their functional expression is acttvely inhibited by production 
of IL-4 by Th2 calls. In this response, the suppressed Thl cells can be phenotypically distinguished 
from the suppressive Th2 cells by the level of expression of CD45RB.  Although the CD45R.B  hxgh 
population mediated a protective response to L. major, C.B-17 scid mice restored with this population 
developed a severe inflammatory  response in the colon that was independent of  L. major infection, 
and was prevented by cotransfer of the CD45KB l~  population.  The colitis appeared to be due 
to a dysregulated Thl response as anti-IFN-% but not anti-IL-4,  prevented it. Taken together, 
the data  show that  the CD4 + T  cell population identified by high level expression of the 
CD45RB antigen contains ceils that mediate both protective and pathogenic Thl responses and 
that  the reciprocal CD45RB l~  population can  suppress both  of these  responses.  Whether 
suppression of cell-mediated immunity is beneficial or not depends on the nature of the stimulus, 
being deleterious  during L.  major infection but crucial for control of potentmlly pathogenic 
inflammatory responses developing m the gut. 
C 
D4  T  cells play a central  role in the induction and 
regulation of the immune response. The CD4 + T cell 
population has been shown to be phenotypically and func- 
tionally heterogeneous.  In the rat, CD4 + T cells that pro- 
duce IL-2 and transfer cell-mediated immune responses in 
vivo can be distinguished by their level of expression of the 
CD45KC antigen from those that provide B cell help (1). 
Such functional heterogeneity can be explained by differen- 
tial cytokine repertoires.  Murine CD4 + T  cell clones have 
been shown to fall into two major subsets: Thl cells that 
produce IFN-3,, TNF-c~ and 8, and IL-2, and that are effldent 
activators of macrophages and NK cells; and Th2 cells that 
are the principal stimulators of antibody production and that 
produce IL-4, IL-5, IL-6, and IL-10, but not IFN-3, or IL-2 
(2). Differential development of Thl or Th2 cells thus deter- 
mines whether a cell-mediated or humoral immune response 
develops. 
Control of Thl and Th2 responses can be exerted at the 
level of Th cell development or on the expression of effector 
functions by mature, differentiated cells. Regarding the latter 
level, studies in vitro suggest that the products of Thl and 
Th2 cells negatively regulate the functions of  each other. Thus, 
IFN-3, inhibits the growth of Th2 clones (3), and IL-10 was 
first identified as a Th2-produced inhibitor of cytokine syn- 
thesis by Thl cells (4). IL-4 has also been shown to inhibit 
IFN-3, production by mitogen-stimulated human PBMC (5, 
6) or mouse CD4 + T  cells stimulated  with soluble antt- 
CD3 (7), although it did not inhibit IFN-3, production by 
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IL-10 synergize to inhibit secondary Thl responses  in vivo 
(8). However, most of the studies of crossregulation of Thl 
and Th2 cells have been performed in vitro, and little infor- 
mation is available on how these populations interact during 
immune responses  in vivo. 
The murine model of L. major-induced cutaneous leish- 
maniasis  has proven  to be  a particularly good model for 
studying Thl and Th2 responses in vivo. Most mouse strains 
infected with L. major mount a strong Thl response to the 
parasite  and heal their infection. In contrast, BALB/c  mice 
mount a Th2 response with the expansion of a CD4 + T cell 
population that produces high levels of IL-4 and low levels 
IFN-~/and that is ineffective  at controlling the growth of 
the parasite  (9). 
We have used the dominant Th2 response  that occurs in 
BALB/c mice as a model to determine whether Th2-mediated 
suppression  of Thl responses  occurs in vivo and how it is 
mediated. Here we present evidence that BALB/c mice con- 
tain L. major-reactive Thl cells whose functions are actively 
suppressed by IL-4 produced by the dominant Th2 popula- 
tion. The "suppressed" Thl cells can be distinguished from 
the "suppressive" Th2 cells by the level of CD45RB expres- 
sion, which permits the study of the functional activities of 
these two populations in isolation and when recombined in 
vitro and in vivo. 
Materials  and Methods 
Animals.  Specific  pathogen-ftee  female  BALB/c  and C.B-17 sc/d 
mice were obtained from Simonsen Laboratories  (Gilroy, CA) and 
maintained in the Animal Care Facility of the DNAX Research 
Institute. C.B-17 scid mice were kept in microisolator cages with 
filtered air. Mice were used at 8-12-wk of age. 
Parasite  lnfiction and L. major  Antigen Preparation.  L. major(WHO 
strain WHOM/-/173) were cultured as promastigotes in M199 
(GIBCO BRL, Gaitbersburg, MD) containing 30%  FCS (J.R. 
Scientific, Woocllond,  CA), 2 ram L-glutamine,  and 100 U/ml each 
of  penicillin  and streptomycin. Promastigotes were harvested  from 
stationary  phase  cultures and washed  in PBS. Animals  were infected 
with 1.5  x  107 promastigotes in the left hind footpad. Parasite 
infection was monitored with a metric cafiper. L. major antigen 
(LmAg)  1 was prepared by four cycles of freezing and thawing of 
the parasites followed by centrifugation. 
Antibodies.  The following mAbs were used for cell purification: 
biotinylated RM-4-5 and ILM-4-4, anti-mouse CD4 and AMS- 
32.1, anti-I-A  a (PharMingen, San Diego, CA); 2-43, anti-mouse 
CD8 (American Type Culture Collection [ATCC] No. TIB210; 
ILockville,  MD); M1/70, anti-mouse Mac-1 (ATCC No. TIB128); 
RA36B2,  anti-mouse  B220 (10);  FITC-conjugated  16A, 
(anti-mouse CD45KB) (PharMingen); PE-conjugated  anti-mouse 
CD4 (Becton Dickinson, Sunnyvale,  CA); and PE-conjugated iso- 
type control mAb (PharMingen). The following mAbs were used 
for in vitro and in vivo assays: 11Bll (rat IgG1), a neutralizing 
anti-mouse IL-4 mAb (ATCC No. HB188), JESS-2A5 (rat IgG1), 
t Abbreviations used in this paper: DLN, draining lymph node; DTH, 
delayed  type  hypersensitivity;  LmAg,  L. major  antigen; MACS, magnetic 
activated cell sorter. 
a neutralizing anti-mouse IL-10  mAb (11), and GLll3 (rat IgG1), 
an isotope control mAb reactive with/5-galactosidase. 
Cell Purification and Flow Cytofluorograph  7.  CD4 + T cell sub- 
sets were purified from the Popfiteal  lymph nodes (draining lymph 
nodes [DLN]) 4-6 wk after L. major infection. Briefly,  cells were 
depleted of B220  +, MAC-1  +, I-A  a+ , and CD8 + cells by negative 
selection using sheep anti-rat coated  Dynabeads  (Robbins Scientific, 
Mountain View, CA), as previously described (12). In some cases, 
CD4 § T ceils were further enriched from the resulting cell sus- 
pension, which was '~,85% CD4+, by positive selection using the 
magnetic activated cell sorter (MACS) according to the manufac- 
turer's instructions (Miltenyi,  Dusseldorf,  Germany). The resulting 
cell population was >96% CD4 §  For separation of CD4 § T cells 
into the CD45RB msL and CD45ILB  ~  populations, negatively 
selected  enriched  CD4 +  T  cells were  labeled with  FITC- 
conjugated anti-CD45RB and PE-conjugated anti-CD4 (Becton 
Dickinson) and fractionated into CD4*  CD45RB h~h and CD4+ 
CD45RB l~ fractions by two-color sorting on a FACStar Plus* 
(Becton Dickinson). The CD45RB~h and CD45RB 1~ popula- 
tions were defined  as the brightest staining 40-50% and the dullest 
staining  15-20% of CD4 §  T  cells, respectively. Intermediate 
staining populations were discarded. In some cases, unseparated 
CD4 + T cells that had been labeled with FITC-anti-CD45RB 
were also sorted. All populations were >98% pure on reanalysis. 
Spleen cells from naive BALB/c mice were depleted of CD4 and 
CD8 staining ceils by negative selection with Dynabeads as de- 
scribed above. The resulting population was >98% CD4 and CD8 
negative and was used as a source of APCs. Flow cytography was 
carried out on the spleen cells from C.B-17 sc/d  mice restored with 
T cell subsets 4-6 wk earlier. Single cell spleen suspensions were 
depleted of erythrocytes by hypotonic lysis and labeled with PE- 
CD4 or PE-conjugated isotope control mAb. Labeled cells were 
analyzed on a FACScan* (Becton Dickinson). 
Reconstitution of C.B-I7 scid Mice with  T  Cell Subpopulations. 
C.B-17 scid mice were injected intravenously with 100/zl of PBS 
containing sorted CD4 + T  cell subpopulations or unseparated 
CD4 + T cells. Mice were infected with L. major 1 d after recon- 
stitution. 
Induction of  Dela?ed Type Hypersensitivity~  (DTH).  Mice  were in- 
jected in the contralateral footpad with 50/~1 of PBS containing 
the equivalent of 5  x  10  s organisms/ml. The protein concentra- 
tion was 250/~g/ml. Footpad swelling  was monitored with a spring- 
loaded metric caliper. 
Histology.  Tissues  were removed from mice 8-12 wk after T 
cell reconstitution and fixed in PBS containing 10% formaldehyde. 
6-/Lm  paraffin-embedded  sections  were cut and stained with hema- 
toxylin and eosin. Photomicrographs were taken on a Axiophot 
Photomicroscope (Zeiss, Obercochen, Germany). 
Recall  Response  to  LmAg  In  Vitr~  CD451LB  hish  and 
CD45RB j~  CD4 + T ceil subsets or unseparated CD4 + T cells 
were cultured in 96-well round-bottomed plates in 250/~1 volumes 
of  R.PMI-1640 containing 5% FCS, 2 mM t-glutamine, 0.05 mM 
2-ME, and 100 U/ml each of  penicillin and streptomycin, together 
with 5 x  10  s APCs in the presence or absence of LmAg (equiva- 
lent,  2  x  10  ~ organisms/ml). APCs were pulsed with LmAg 
(equivalent, 2  x  10  ~ organisms/ml) or medium alone for 4 h and 
then exposed to 1,000 rad 3~-irradiation. Supernatants from dupli- 
cate cultures were harvested after 72 h and pooled for detection 
of cytokine synthesis. 
Detection of Cytokines.  Cytokine levels in supernatants  were de- 
tected  by two-site sandwich  ELISA  as previously  described  for IFN~ 
(13), Ib4 and ID10 (11), and ID3 (14). Samples were assayed in 
duplicate and quantitated by comparison with standard curves of 
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Figure  1.  Ib4 and IL-10  production by CD4 + T cells from mice with 
chronic leishmaniasis inhibits IFN-7 production in vitro. CD4 + T cells 
positively  selected on the MACS from L. major-infected  BALB/c mice were 
stimulated at 5  x  105 ceils/weU with LmAg and T cell-depleted spleno- 
cytes. Antibodies were added to cultures at 10 pg/ml. Supernatants were 
removed after 72 h and IPN-3, levels determined. Data are expressed as 
a percentage of the levels  obtained with LmAg alone (1.6 ng/ml) and rep- 
resent the mean of duplicate cultures plus SEM. CD4 § T cells cultured 
in the absence of antigen produced <0.3 ng/ml IFN-T. Three further ex- 
periments gave similar results. 
purified recombinant or natural cytokine. Results are presented as 
the mean  -+  SEM. 
Results 
IFN-T Production by CD4 + T  Cells Is Inhibited by IL-4 
and IL-IO Production during a Th2 Response to L. major 
in BALB/c Mice 
Infection  of BALB/c  mice with  L.  major results  in  the 
preferential expansion in the DLN of Th2 cells that contain 
high levels of IL-4 and IL-10 mRNA  (15) and that produce 
these cytokines upon in vitro stimulation  (16). Despite this 
dominant Th2 response, low levels of IFN-7 are also consis- 
tently observed (16,  17).  It seemed possible that the poten- 
tial to produce  IFN-T in response to L.  major may be un- 
derestimated because of the concomitant production of IL-4 
and IL-10 in the cultures,  as both IL-4 and IL-10 have been 
shown  to inhibit  IFN-3, production,  in vitro and in vivo. 
To test this,  CD4 + T  cells were purified from the DLN of 
L. major-infected BALB/c mice and restimulated in vitro with 
LmAg and T  ceU-depleted splenocytes from naive BALB/c 
mice as a source of APCs.  Neutralization  of IL-4 or IL-10 
production in the cultures, by addition of anticytokine mAbs, 
led to twofold increases in the level of IFN-7 detected com- 
pared with medium or isotype control-treated cultures (Fig. 
1), confirming active inhibition of IFN-7 production by both 
of these cytokines. 
The Level of Expression of CD45RB Distinguishes 
IFN-T-producing from IL-4-producing CD4 + T  Cells 
To address whether IFN-7 was being made by a separate 
subpopulation  of CD4 §  T  cells from those  that produced 
the IL-4 and IL-10 that regulated it, the CD4 + T  cell popu- 
lation isolated from the DLN was further  subdivided into 
two fractions based on the levd of expression of the CD45RB 
antigen. FACS*-sorted CD45RBh~ and CD451LB  l~  CD4 + 
T  cells were restimulated in vitro with LmAg and T  cell- 
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Figure  2.  In the recall response to L. major, the 
IFN~ prod,_  _  _,,~ can be distinguished from the IL,4 
producers based on the level of expression of the 
CD45RB  antigen.  CD4 + T  cell subsets from 
L. major-infected BALB/c mice were stimulated 
with LmAg and T cell-depleted splenocytes. (D) 
CD4 § T cells; (O) CD45RB~ CD4 + T cells; 
(O) CD45RB~  h CD4 § T cells. After 72 h of 
culture, supm~tants were collected and assayed  for 
cytokine levels. Data represent the mean value of 
duplicate cultures plus SEM. Cytokine levels  were 
undetectable when the cells were cultured in the 
absence of LmAg; <0.3  ng/ml  IFN-T, <0.15 
ng/ml IL-4,  <0.15 ng/ml IL-3. Two further experi- 
ments gave similar results. 
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3 d of culture and assayed for cytokine content. The result 
from  a  representative  experiment  is  shown  in  Fig.  2. 
CD45RB  hizh and CD45RB  l~  CD4 + subpopulations  pro- 
duced equivalent amounts of IL-3 in response to L. major, 
indicating comparable activation by the antigen;  however, 
IL-4 and IFN-7 levels varied depending on the phenotype 
of the responding CD4 + T  cells. The CD45RBhig  h subset 
produced the highest levels of IFN-7, being approximately 
fourfold more potent in this regard than the CD45RB  l~ 
subset. In contrast, the CD45RB  1~  population was 10-fold 
more potent  in  IL-4  production  than  the  CD45RB~s  h 
subset. In other experiments,  IL-10 was measured and was 
also found to be produced preferentially by the CD45RB  l~ 
population (data not shown). Cytokine production was an- 
tigen specific as cytokine levels were below the limit of de- 
tection in cultures that did not contain LmAg. Further, the 
response to LmAg was dependent on priming of the T cells 
as CD4 + T  cell subsets isolated from the spleen of naive 
recipients failed to synthesize detectable levels of IL-4, IL-3, 
IFN-7, or IL-10 in response to stimulation with LmAg (data 
not shown). These data show that primed L. major-reactive 
Thl cells are present in BALB/c mice with nonhealing leish- 
maniasis, and that they can be distinguished  from the Th2, 
IL-4 producers by the level of expression of the CD45RB 
antigen. 
Adoptive  Transfer of L.  major Reactivity  to 
C.B-I7 scid Mice 
CD4 + T  Cells  Transfer Nonhealing  Th2-1ike Responses to 
L. major-infected scid Mice.  To test whether the correlation 
between CIM5RB phenotype and function evident in response 
to L. major in vitro was relevant in vivo, CD45R.B  high and 
CD45RB  l~  CD4 + T cells were purified from the DLN of 
L  major-infected BALB/c mice and transferred to congenic 
C.B-17 scid mice. Recipients were infected with L. major at 
the time of T cell reconstitution,  and disease progression was 
monitored by quantitation of footpad swelling at the site of 
initial infection and by histological analysis of the infected 
footpads 5-7 wk after infection Dissemination of the para- 
site was documented  by histological analysis of the liver and 
parasite culture from the spleen. As preciously described, 
CD4 + T cells from L. major-infected BALB/c mice trans- 
ferred a nonhealing response to parasite-infected  scid mice (Fig. 
3 A), very similar to that which occurs in the donor mice 
(Correa-Oliveira, P,., and R. L. Coffman, unpublished data). 
This T cell-mediated nonhealing response, which is ultimately 
fatal, differed  from the disease  course of  unreconstituted C.B-17 
scid mice, which have no B or T cells (18). The latter were 
highly susceptible to L.  major infection,  developing a late 
footpad swelling that progressed rapidly (Fig. 3 A). By 4-5 
wk, the parasite had disseminated,  often causing death by 
12 wk. Compared with unxestored control mice, CD4 + T 
cell-restored mice developed an earlier footpad swelling that 
increased in size more slowly (Fig. 3 A). Consistent  with 
the footpad swelling,  disease progression  was  slower and 
animals could survive for up to 5 mo with this chronic lesion 
(data  not  shown),  indicating  that  even  these  "disease- 
promoting" CD4 + T cells from infected BALB/c mice did 
provide some protective immunity to the parasite. 
Transfer of the CD4RBhig h CD4 + T  Cell Subset to L. major- 
infected CB-17 scid Mice Leads to a Healing 771I Respons~  Con- 
sistent with the different profiles of cytokine production by 
the CD45RB~g h and CD45RB l~  CD4 + subpopulations in 
response to L. major antigen in vitro, the outcome  of L. major 
infection in scid mice restored with these subsets was very 
different. Transfer of 5  x  10  s CD45RBhig  h CD4 + cells led 
to a healing pattern of  disease  characterized  by an initial footpad 
swelling that by 6 wk had resolved (Fig. 3 B). Histological 
analysis of the footpads taken 6-8 wk after infection revealed 
an extensive leukocytic infiltrate with very few live parasites 
inside the macrophages (data not shown). The parasites ap- 
peared not to have disseminated to the viscera as they were 
not detectable upon histological analysis of spleen or liver, 
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Figure 3.  Adoptive transfer of L. major  responses to C.B-17 sc/d mice with CD4 * T cell subsets.  CD4 + T cell subsets from L. major-infected BALB/c 
mice were injected intravenously at different doses into C.B-17 scid mice that were infected with L. major I  d later. Data represent the mean footpad 
swelling plus SEM. Data were pooled from two independent experiments. Numbers in parentheses indicate the number of animals in each group. 
Two further experiments gave similar results. 
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Figure 4.  DTH responses  in L. major-infected  C.B-17 sc/d  mice  restored 
with CD4 + T cell subsets. C.B-17 scid mice were reconstituted with 
CD4 + T cell subsets and infected  with L. major  as described in Fig. 3. 
5 wk after  infection,  mice  were  challenged  with LmAg  in the contrahteral 
footpad and the swelling  measured after 48 h. Data represent the mean 
value of two animals  per group plus SEM. A further experiment gave a 
similar result. 
nor could they be cultured from splenocyte preparations (data 
not shown). As few as 104 CD45RB  high CD4 + T cells were 
capable of transferring a healing response (Fig. 3 B). Healing 
correlated with the induction of Thl immunity as these mice 
gave large DTH responses  (a function of Thl and not Th2 
cells) upon challenge with LmAg (Fig. 4). Further, the healing 
response was dependent on IFN-v production, as adminis- 
tration of anti-IFN-v mAb led to the abrogation of protec- 
tive immunity. Compared with animals that received an iso- 
type control mAb, anti-IFN-"/-treated mice developed a large 
footpad lesion (Fig.  5 A) and dissemination of the parasite 
to the spleen  and liver (data not shown). 
CD45RB ~w CD4 + T  Cells Transfer a Nonhealing  Th2 Re- 
sponse to L major-infected C.B-17 scid Mic~  In contrast to the 
result above, scid mice restored with 5  x  10  s CD45RB  l~ 
CD4 +  T  ceils  exhibited  a  nonhealing pattern  of disease, 
similar to mice restored with the same number of unsepa- 
rated CD4 + T  ceils (Fig.  3 C). Large numbers of parasite- 
laden macrophages were evident in the footpads of these mice 
5-6-wk after infection (data not shown), indicating that the 
increase in footpad swelling reflected the inability of the trans- 
ferred T cells to control the growth of the parasite. By 6 wk, 
parasites had disseminated to the viscera and were visible upon 
histological examination of spleen and liver sections and could 
be cultured in vitro from spleen cell preparations (data not 
shown). Compared with healing CD45RB~h-restored mice, 
the CD45RBl~  mice made barely detectable DTH 
responses to soluble L. major antigens (Fig. 4), indicating im- 
paired cell-mediated (Thl) immunity towards the parasite. 
The response transferred by the CD45RB  l~  population was 
not simply due to a lack of immunity towards L. major, but 
rather to transfer of disease-promoting Th2 cells, as a healing 
response to the parasite  occurred in mice treated with anti- 
IL-4 mAb (Fig. 5). A healing response also developed when 
lower numbers of CD45RB  l~  CD4 + T  cells were trans- 
ferred. Thus, when 10  s cells were transferred, only two of 
nine mice developed  nonhealing progressive  disease (Fig.  3 
C),  whereas  the remaining seven mice developed a  small 
footpad lesion that was resolved. The situation was even clearer 
when 0.3  x  10  s cells were transferred, as all of the mice in 
this group exhibited a healing disease pattern (Fig.  3  C). 
CD45RB h~ CD4 + T  Cells Suppress the Protective 
Immunity  Transferred to scid Mice  by the CD45RBhi* h 
Population via an IL-4--dependent Mechanism 
5  x  10  s CD45RBhis  h CD4 + T cells transferred a healing 
Thl response to L. major-infected scid mice, however,  5  x 
10  s  CD4 +  T  calls,  which contain 60-70%  CD45R.Bhis  h 
cells, transferred a nonhealing Th2 response, suggesting that 
the CD45RB  I~  subset inhibited the transfer of protective 
immunity by the CD45RBhi# subset. To test this suppres- 
sion directly and determine its mechanism of action, subsets 
of CD4 + T cells were purified from the DLN of L. major- 
infected BALB/c mice and injected alone or in combination 
into L. major-infected  scid mice. As described above (Fig. 3), 
transfer of 4  x  10  s CD45RBh~  h cells led to resolution of 
the lesion (Fig. 6 A) and a healing pattern of disease, whereas 
transfer of 4  x  10  s CD45RB  l~  cells led to a progressively 
increasing lesion  size  and nonhealing disease  (Fig.  6 A). 
Cotransfer of both subsets together also led to a nonhealing 
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Figure  5.  Transfer  of the healing  response by the 
CD45RB~h population  or the nonhealing  response 
by the CD45RB  ]~  population to L. major-infected 
sc/d mice is dependent on IFN-v or IL-4  production, 
respectively.  C.B-17  sc/d  mice  were reconstituted  with 
CD4 + T cell subsets and infected  with L. major  as 
described in Fig. 3, except that some animals were 
treated at the time of infection and 10 d later with 
anti-IFN-v (2 mg/injection), anti-II.,-4  (5 mg/injec- 
don), or isotype  control  mAb GLl13  (5 mg/injection). 
Values represent the mean plus SEM for the group. 
Numbers in parentheses  indicate  the number  of animals 
in each group. 300" 
200" 
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Figure  6.  CD45RB l~  CD4 §  T  cells  inhibit  the  Thl 
response  transferred  by  the  CD45RBhig  h  population  to 
L. major-infected sc/d mice via an Ib4-dependent mechanism. 
C.B-17  sc/d  mice  were  reconstituted  with  CD4 +  T  cell 
subsets and infected wiPa L. major  as described in Fig. 3 and 
treated with anticytokine mAb or control mAb as described 
in Fig. 5, e~cept that 2 rag/injection of anti-IL-10 was given. 
(A) Animals received 4  x  los CD45RBhig  h (0),  4  x  los 
CD45RBhig  h  plus  4  x  los  CD45RBIo~  ([2]),  4  x  10  s 
CD45RBhig  h plus 4  x  los CD45RB low plus anti-Ib4 (A), 
4  x  105 CD45RB~ h plus 4  x  ]0  s CD45RB low plus anti- 
Ibl0 (O), 4  x  105 CD45RB~ h plus 4  x  los CD45RB tow 
isolated from naive donors (B), 4  x  105 CD45RB l~  (A). 
(B) 106 CD4 + T  cells plus GLl13 (0),  anti-Ib4 (O), anti- 
IL-10 (A).  Data are expressed as the mean value plus SEM 
for four to five animals per group. 
pattern of disease (Fig. 6 A), indicating that the CD45RB ~w 
population did indeed suppress the transfer of a Thl response 
by  the  CD45RBhig  h  population.  Suppression  of  the 
CD45RB high population by CD45RB l~  ceils was antigen 
specific  and  required  priming  as  cotransfer of 4  x  10  s 
CD45RB bw CD4 + T cells from the spleen of naive BALB/c 
mice with the primed CD45RBh~ h population did not in- 
hibit the healing Thl response (Fig.  6 A). 
As the concomitant production of IL-4 and IL-10 was 
shown to inhibit IFN-3, production by CD4 + T ceUs in re- 
sponse to L. major in vitro (Fig.  1), the role of these cyto- 
kines in  the suppression  of the CD45RB high calls by the 
CD45RB l~  population in vivo was tested. Mice given the 
combination of CD45RB high and CD45RB ~'v CD4 + T ceils 
were treated at the time of L. major infection and 10 d later 
with anti-IL-4 or anti-IL-10 mAbs. Treatment with anti-IL-4 
prevented  the  inhibition  of  the  Thl  response  by  the 
CD45RB L'w population and led to resolution of the L. major 
infection with a pattern of lesion development similar to mice 
reconstituted with only CD45RBhig  h ceils  (Fig.  6 A).  In 
contrast,  anti-IL-10  treatment had  no effect on the sup- 
pression  of  the  CD45RB high population.  These  animals 
developed a footpad swelling indistinguishable from mice 
given both CD45ILB high and CD45RB l~  cells (Fig. 6 A). 
When 106 unseparated CD4 + T  cells were transferred, re- 
sults were obtained identical to those of the mixture of sorted 
CD45RB high and CD45RB l~  cells.  Treatment with anti- 
IL-4, but not anti-IL-10 or an isotype control mAb, prevented 
the suppression and revealed protective immunity (Fig. 6 B). 
Injection of CD45RB hish CD4 + T  Cells Led to Greater 
T  Cell Reconstitution  than the Reciprocal 
CD45RB h~ Subset 
Transfer of Thl or Th2 immunity did not appear to corre- 
late with the total reconstitution potential of the donor cell 
population. Equivalent numbers of CD4 + T ceils were de- 
tectable in the spleens of mice 4-6 wk after injection of 5  x 
10  s unseparated CD4 + T  cells (0.88  x  106  +  0.29  x  106, 
n ~  4), which transferred a Th2 response to the parasite (Fig. 
3 A), or 5  x  103 CD45RB high cells (0.83  x  106  _+ 0.2  x 
106, n  -- 4) which transferred a healing response (Fig. 3 B). 
However, mice restored with the CD45RB l~  CD4 + popu- 
lation contained threefold fewer (0.29  x  106  +  0.08  x  106, 
n  =  3)  CD4 + T  cells  in  the spleen.  The level of T  cell 
reconstitntion produced by the two subsets correlated with 
the potential of these populations to transfer a healing re- 
sponse to L. major infection at low cell numbers, as the ability 
to transfer a healing response to L. major began to titrate out 
at a dose of 104 CD45RB l~  ceils, whereas this point was 
not reached until 10-fold fewer (103) CD45RB  high cells were 
transferred (data not shown). 
Scid Mice Restored with CD45RB~g ~ CD4 + T  Cells 
Developed a Severe Inflammatory Response  in the  Colon 
which  Was Prevented by Anti-IFN-7  mAb 
During the course of these experiments, it was noticed 
that despite healing their L. major infection, animals that re- 
ceived 1-5  x  103 CD45RBhlg  h CD4 + T  cells developed a 
wasting disease 5-8 wk after infection (data not shown). The 
wasting disease was accompanied by severe pathology in the 
colon, characterized by extensive mononuclear cell filtrates, 
ulceration, and pronounced epithelial cell hyperplasia (Fig. 
7, E-F; Table 1). Induction of colitis in C.B-17 scid mice by 
transfer of CD45RBhig  h CD4 + T  cells was not dependent 
on L. major infection, as an identical lesion occurred in unin- 
fected C.B-17 scid mice restored with CD45RB high CD4 + 
T cells isolated from naive C.B-17 (19) or BALB/c mice (12). 
Concurrent infection with L. major did not affect the kinetics 
of the wasting disease or the incidence or severity of the co- 
litis (data not shown). We have previously shown that the 
pathology in the colon was accompanied by significant in- 
creases in IFN-3' and TNF-c~ mRNA transcripts, but not 
in IL-4 or IL-10 mRNA levels, suggesting that it may be 
Thl mediated (12). Indeed, IFN-7 was involved in the patho- 
genesis, as sc/d mice that received CD45RB h~h CD4 + T cells 
together with anti-IFN-7 had a reduced incidence of severe 
colitis (0/4, Table 1), compared with animals that received 
CD45RB  hish cells alone (10/12, Table 1), or together with 
anti-IL-4 mAb (4/4, Table 1), or GLl13, an isotype control 
mAb (4/4,  Table  1). 
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by the CD4  5RBh~g  h Population 
Animals injected with the CD45RB  l~  subset of CD4 + 
T cells did not develop the colitis (Table 1); colons from these 
mice were indistinguishable from those of normal BALB/c 
mice  (Fig.  7,  A  and  B).  This  population  also  prevented 
induction of colitis by the CD45RBhig  h population as ani- 
mals  that  received unseparated  CD4 +  T  cells  or purified 
CD45RB  high cells with CD45RB  l~  cells at either a 2:1 or 
1:1 ratio developed a significantly reduced incidence of severe 
colonic pathology (pooling these groups 3/17, Table 1) than 
animals  that  received  CD45RBhi8  h  cells  either  with  or 
without isotype control mAb (14/16, Table 1). Mild pathology 
was  evident in 7/17 mice restored with  CD45RBhis  h and 
CD45RB  l~  CD4 + T  cells, which consisted of a small leu- 
kocytic infiltrate and limited hyperplasia (Fig.  7, C and D). 
Inhibition of the Thl response to L. major was mediated by 
IL-4-producing Th2 cells (Fig. 6), however in these experi- 
ments, in which anti-IL-4 or anti-IL-10 was administered, 
no significant increase in the incidence of severe colitis was 
observed (Table  1), suggesting that the CD45RB  I~  popu- 
lation may regulate the development of colitis by a mecha- 
nism other than IL-4 and IL-10 production. 
Discunion 
The host response to invading microorganisms is tightly 
regulated  to  ensure activation of appropriate immune el- 
lector functions to eliminate the infectious agent without 
destroying "self'. Our data indicate that interactions between 
CD45RB~  h and CD45RB  l~  subsets  of CD4 + T  cells play 
a critical role in this process.  CD45RB~  h CD4 + T  cells, 
Figure 7.  CD45KBhIO  CD4 § T cells  induce  colitis  in C.B-17 sc/d  mice. C.B-17  sc/d  mice  were reconstituted  with CD4 § T cell subsets and infected 
with L. major as described  in Fig. 3. Mice were killed 8 wk after reconstitution  and para~n-embedded  sections of colon stained with hematosylin 
and eosin. Distal colon from: normal BALB/c  mouse (,4 and B), C.B-17 sc/d that received  4  x  10  s CD45KB~ plus 2 x  10  s CD45RB  1~  cells (C 
and D), C.B-17 sc/d that received  4  x  10  s CD45RBh~  h cells (E and F). (,4, C, E)  x17; (B, D, F)  x162. 
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Phenotype of CD4 § T  mAb 
cell inoculum  treatment  Minimal 
Colitis (12-14 wk) 
Mild  Severe 
1-5  x  105 CD45RB  high 
2-5  x  10  s CD45RB l~ 
4  x  10  s CD45R.B  hish 
+  2  x  10  s CD45 l~ 
4  x  10  s CD45RB~as  h 
+4  x  10  s CD45RW  ~ 
6-10  x  10  s CD4 + 
-  0/12  2/12  10/12 
GLll3  0/4  0/4  4/4 
anti-IL-4  0/4  0/4  4/4 
anti-IFN-~  1/4  3/4  0/4 
-  6/6  0/6  0/6 
0/3  2/3  1/3 
-  1/5  3/5  1/5 
anti-IL-10  3/4  1/4  0/4 
anti-IL-4  3/5  1/5  1/5 
GLl13  6/9  2/9  1/9 
anti-IL-10  3/5  0/5  2/5 
anti-IL-4  3/4  1/4  0/4 
C.B-17 sc/d mice were reconstituted  with CD4 + T cell subsets and infected  with L. major and treated with anticytokine  or isotype control mAb 
as described in Fig. 5. Mice were killed  8-10 wk after  infection  and colons scored for pathology.  Minimal, indistinguishable  from control BALB/c 
mice (Fig. 7, A and/3); mild, limited  mononuclear  infiltrates  and slight  epithelial  cell hyperphsia  (Fig. 7, C and D); severe, extensive  mononuclear 
cell infiltrate and marked epithelial cell hyperplasia (Fig. 7, E and F). Data were pooled from three independent experiments. 
isolated from L.  major-infected BALB/c mice transferred a 
protective Thl response to L. major-infected scid mice; how- 
ever, a lethal inflammatory response developed in the colon 
of these mice. The CD45RB  l~  CD4 + population prevented 
the development of colitis when transferred together with 
the CD45RBhi~ h population.  However, the protective an- 
tileishmanial response was also inhibited and the mice devel- 
oped visceral leishmaniasis.  Based on these data we propose 
that the ddeterious suppression of cell-mediated immunity, 
which in some instances occurs in response to infectious 
microorganisms, may be the price to be paid for the immu- 
noregnlation, which under normal circumstances, prevents 
the development of inflammatory responses  to immunolog- 
ical self-antigens,  including the intestinal flora. 
4 wk after infection, BALB/c mice infected with L. major 
show few signs of a functional Thl response in vivo.  Such 
mice have no DTH reactivity to parasite antigens and exert 
little ff any control of the growth or spread of the pathogen 
(9). However, we present evidence herein that these mice do 
contain a significant population of primed Thl ceils whose 
function was actively suppressed by the dominant Th2 ceils. 
In the CD4 + T cell response to LmAg in vitro, IFN-3, levels 
were significantly increased by neutralization of IL-4 and IL-  10 
produced in the cultures. Separation of the CD4 + T  cells 
into CD4RBhI8  h or CD45RB  bw fractions revealed that the 
LmAg-specific IFN-q,-producing cells were contained within 
the  CD45RBhig  h  population,  whereas  the  specific  IL-4- 
producing  ceils  were  contained  within  the  reciprocal 
CD45RB  L~" population. Thus, the minority Thl population 
was phenotypically distingnishable from the dominant Th2 
population. 
The regulatory interaction between L. major-reactive Thl 
and Th2  populations and the correlation with CD45RB 
phenotype  was  confirmed  in  vivo.  5  x  105  CD4 +  or 
CD45RB l~  CD4 + T  ceils from mice with chronic leish- 
maniasis adoptively transferred a nonhealing Th2 response 
to L.  major-infected  C.B-17 scid mice. However, 4  x  105 
CD45RB~  h ceUs (which comprise m70% of CD4 + T ceils) 
transferred a healing Thl response,  suggesting that in the 
transfers of CD4 + T  cells, the protective potential of this 
population was inhibited by CD45RB  l~  calls. The domi- 
nant suppressive effects of the CD45RB  l~  population were 
illustrated by the fact that cotransfer of 4  x  105 CD45RB  l~ 
cells with 4  x  105 CD45RBh~ cells led to a nonhealing Th2 
response.  Identical results were obtained when CD45tLBhlg  h 
and CD45RB  l~  CD4 + T ceils were mixed at their physio- 
logical ratio of 2:1 (data not shown). Suppression of the Thl 
response to L. major required specific antigen recognition as 
it could be mediated by CD45RB  l~  cells from L.  major- 
primed but not naive recipients.  The most direct interpreta- 
tion of these data is that primed Thl cells exist in the DLN 
of mice making a dominant Th2 response to L.  major, but 
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cells. 
In a series of pioneering studies in the early 1980s, Liew 
(20) showed that CD4 + T cells existed in BALB/c mice in- 
fected with L. major which could suppress DTH responses 
to LmAgs, although it was not possible at that time to pheno- 
type these cells or determine their mechanism of action. Sev- 
eral studies support our conclusion  that Thl cells exist in 
mice with chronic leishmaniasis. The frequency of L. major- 
specific T cells capable of mediating delayed type hypersensi- 
tivity responses was found to be substantially higher in the 
DLN of nonhealing BALB/c mice than in healing CBA mice 
(21), and that both Thl and Th2 L.  major reactive clones 
could be generated from BALB/c mice with chronic leish- 
maniasis (22). Further, in a study of a number of inbred mouse 
strains infected with L. major, the level of expression of IL-4 
mRNA was  found to  correlate  with nonhealing disease, 
whereas IFN-'y mRNA levels were similar between healing 
and nonhealing strains (23). 
A lack of cell-mediated immunity is a feature of a number 
of infectious diseases and it has been suggested that Th2- 
mediated suppression of Thl responses may in part account 
for this (24). Apart from the studies described here, Th2- 
mediated suppression has been studied largely in vitro and 
has focused on the role of IL-10. Thus, it has been shown 
that addition of anti-IL-10 to cultures  of spleen cells from 
mice infected with Schistosoma mansoni  enhanced IFN-'y pro- 
duction in response to parasite antigens (25). A similar effect 
was seen when anti-IL-10 was added during Con A stimula- 
tion of spleen cells from mice infected with the hehninth 
Nippostrongylus brasiliensis (26). The effects of IL-4 were not 
analyzed in these studies. In studies with mouse T cell clones, 
IL-10 but not IL-4 inhibited Thl cytokine synthesis (4). How- 
ever, suppression of Thl responses by both IL-4 and IL-10 
has been described in a number of  parasite diseases  in humans. 
IL-4  was  shown to be one of the activities produced by 
CD8 + T cell clones isolated from patients with lepromatous 
leprosy that inhibited the proliferation  of Thl clones (27), 
and neutralization of IL-10 and, to a lesser extent IL-4, led 
to enhanced IFN-3'  synthesis by PBL from patients  with 
visceral leishmaniasis (Carvalho, E.M., personal communi- 
cation). Our studies indicate that, in the dominant Th2 re- 
sponse to L. major  in vitro, both IL-4 and IL-10 inhibit IFN-'y 
production. It may be that in some situations  IL-4 will be 
more effective than IL-10 in suppression of Thl functions 
and vice versa. 
Differences in the role of IL-4 and IL-10 in suppression 
of  Thl responses to L. majorwere  evident in the in vivo studies. 
Administration of anti-IL-4, but not anti-IL-10, to L. major- 
infected scid mice restored with a mixture of CD45KB ~sh 
and CD45RB l~  ceils led to the development of protective 
Thl responses, suggesting that the CD45RB l~  population 
inhibited the Thl response to L. major in vivo by an IL-4- 
dependent mechanism. It is not clear why anti-IL-10 was effec- 
tive in vitro but not in vivo, however these two forms of 
analysis are very different as the former consists of an acute 
3-d restimulation, whereas the latter requires expansion of 
the donor cell population.  The finding that anti-IL-10 failed 
to modulate the adoptive  transfer of the Th2 response to 
L. major is consistent with the finding that anti-IL-10 had 
no effect on the course of L.  major infection  in BALB/c 
mice (16). 
CD45RB~  h and CD45RB l~  subsets of mouse CD4 + T 
ceils are widely thought to represent naive and memory T 
cells, respectively. The CD45RB antigen is lost on T  cell 
activation in vitro (28) and in vivo (29). CD45RBhig  h CD4 + 
ceils from naive donors provided help to B ceils in assays of 
primary antibody responses, whereas the CD45RB  1~  popu- 
htion was active in memory  responses (29); the recall response 
to KLH for both Thl and Th2 cytokines was shown to be 
contained within the CD45RB  l~  population (30). How- 
ever,  after  infection  with  L.  major, primed  L.  major- 
reactive CD4 § T cells can be found in both the CD45RB~  h 
and CD45RB l~  CD4 + populations.  On a ceil/cell basis, 
antigen-stimulated CD45RB~  h and CD45R_B  l~  popula- 
tions produced equivalent amounts of  IL-3 in vitro, suggesting 
approximately equivalent levels of activation. However, the 
CD45RB hlgh population produced predominantly IPN-'y, 
whereas the CD45RB l~  subset was the more potent pro- 
ducer of antigen-stimulated IL-4. As the recall response to 
LmAg requires infection or immunization with L. major in 
vivo, these results indicate that the CD45RBhig h population 
contains most of the L. major-reactive  Thl cells, whereas the 
CD45KB  l~  population  contains most of the L. major-reac- 
tive Th2 ceils. Although these results differ from previous 
studies with a defined protein antigen, the two studies are 
very different as infection with L. major  leads to chronic stim- 
ulation and a relatively polarized Th2 response, whereas im- 
munization with KLH together with Bordetella pertussis ap- 
peared to activate a more acute and mixed Thl  and Th2 
response (30). 
Our data taken together with those of others, suggest that 
the  CD45R.B hlgh CD4 + population  is  heterogeneous and 
made up of naive cells together with, in some circumstances, 
primed Thl cells. A similar heterogeneity has been postu- 
lated to occur within the CD45R.B high CD4 + T cell popu- 
lation in  humans which was  shown to  be comprised of 
CD45RA + and CD45RA- cells (31). The finding that the 
CD45RB l~  population contained  the L. major-responsive 
Th2 cells is consistent with previous reports that this popu- 
lation produced high levels of IL-4 in response to mitogens 
and specific antigen (29,  30,  32).  However,  the adoptive 
transfer of Th2 responses to L. major-infected C.B-17 scid 
mice by the CD45RB l~  popuhtion was complicated by the 
fact that Thl responses could be revealed by treatment of the 
recipients with anti-IL-4 or by transfer of low numbers (3 x 
104-1  x  10  s) of CD45RB l~  ceils. It is not clear whether 
this finding represents the preferential outgrowth of a small 
number of contaminating CD45RB high Thl cells that are 
suppressed  by the IL-4 producers  at high cell number, or reflects 
a true functional heterogeneity of the CD45RB I~  popula- 
tion. Experiments with genetically marked cell populations 
will be required to distinguish between these two possibili- 
ties. A  shift  to  Thl  responses with  the transfer  of low 
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tionated  CD4 +  T  cells  from  L,  major-infected  donors 
(Correa-Olivera, R., and R. L. Coffman, unpublished data) 
and appears to be due in part to the dominance of  s0id-derived 
IFN-% Combining data from a number of studies, including 
this one, it is dear that the regulation of expression of the 
CD45RB  antigen is complex and caution should be exer- 
cised when assigning a population a particular function based 
on the level of expression of this antigen alone. Use of mAbs 
that  further subdivide the CD45RB  subsets of CD4 + T 
cells may clarify the situation. 
Scid mice restored with CD45R.B  high CD4 + T cells from 
L. major-infected BALB/c mice healed their L. major infec- 
tion but developed a progressive inflammatory response in 
the colon. Colitis was, however, not mediated by L. major- 
specific T  calls as it has been shown to occur equally well 
in C.B-17 scid mice restored with the CD45RB  hiSh popula- 
tion isolated from naive BALB/c (12) or C.B-17 mice (19). 
The colitis appeared to be a manifestation of a dysregulated 
Thl response with the expression of high levds of IFN-3, 
and TNF-c~ mKNA in diseased colons (12). Further, the co- 
litis in mice reconstituted with CD45RB  hish CD4 + T cells 
was significantly diminished by treatment with anti-IFN-% 
but these mice developed instead a nonhealing Th2 response 
to L. major infection. Thus, Thl immunity is a double-edged 
sword, capable of generating both protective and pathogenic 
responses in the host at the same time. 
The nature of the antigenic stimulation that leads to the 
development of colitis in the CD45KBhi~h-restored  mice is 
presently unknown.  It may be an inflammatory response 
against components of the gut flora, as has been suggested 
to occur in inflammatory  bowel disease in humans (34). Rele- 
vant to this, colitis similar to that described here developed 
in mice that lacked a functional IL-2 gene when housed under 
conventional conditions, but not when maintained in a germ- 
free environment (35). Whatever the nature of the antigenic 
drive, it is clear that the development of the Thl-mediated 
pathology  in  the  colon  of mice  given  the  CD45RBhig  h 
subset is inhibited under normal circumstances by cells con- 
tained within  the CD45RB l~  population.  Mice restored 
with  unseparated  CD4 +  T  cells,  or  with  a  mixture  of 
CD45RB  hiSh and CD45RB I~  cdls did not develop colitis. 
Thus the CD45RB bw population suppressed both protective 
and pathogenic Thl responses mediated by the CD45RB  high 
population. This illustrates the importance of appropriate ac- 
tivation of this subset, which mediates beneficial regulation 
of immune responses  in the gut but inhibits protective re- 
sponses  to intracelhlar pathogens like L.  major. 
Suppression of the Thl response to L. major was depen- 
dent on IL-4 production, however, anti-IL-4 treatment failed 
to block the protective effect of the CD45RB l~  ceils on co- 
litis induction or to induce colitis in mice that received un- 
separated CD4 + T  cells.  This suggests that the cells that 
regulated the colitis acted via a different mechanism to those 
that inhibited Thl immunity to L. major. There is evidence 
that IL-10 plays an important role in regulation of inflamma- 
tory responses in the intestine as mice with a targeted dis- 
ruption of the IL-10 gene developed a wasting disease and 
severe enterocolitis (36). However anti-IL-10 mAbs also failed 
to  inhibit  the protection  by  the  CD45RB bw  cells,  sug- 
gesting that IL-10 was not the key regulatory molecule in 
this model of colitis. It may be that other suppressive cytokines 
produced by Th2 cells are more important in the colitis that 
develops in the CD45RBhis h CD4 + T cell-restored scid mice. 
Alternatively, the regulators of colitis may have a cytokine 
profile distinct from Th2 cells. In this regard, multiple inflam- 
matory lesions, including colitis, developed in mice with tar- 
geted disruption of the TGF-/$1  gene (37,  38),  and IL-2- 
deficient mice developed colitis (35). 
Multiple organ inflammation developed in nude rats recon- 
stituted with CD45KCh~8  h CD4 §  T  cells which was pre- 
vented by the CD45RC I~  population (39). Further, transfer 
of CD454RC 1~  population  from normal rats  into  adult 
thymectomized, sublethally irradiated redpients prevented the 
development of spontaneous diabetes in the redpients (40). 
The finding that similar regulatory interactions exist between 
the  subsets  of CD4 +  T  cells  identified on  the basis  of 
CD45KC in the rat and CD45RB in the mouse emphasizes 
the importance of this regulatory pathway. 
In summary, separation of the CD4 + T  cell population 
into the CD45RB~ h and CD45KB l~  subfractions has re- 
vealed two populations that mediate distinct immunological 
functions. Regulatory interactions were shown to occur be- 
tween these subsets which were important in the response 
to L. major and in a modd of colitis.  Study of these subsets 
may therefore provide a useful model for defining the regula- 
tory interactions that occur within the CD4 + T  cell popu- 
lation and that are important in the host response to infec- 
tious agents and the maintenance of peripheral tolerance. 
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